Cargando…

Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis

BACKGROUND: While prior research has provided important information about readmission rates following percutaneous coronary intervention, reports regarding charges and length of stay for readmission beyond 30 days post-discharge for patients in a large cohort are limited. The objective of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Meadows, Eric S, Bae, Jay P, Zagar, Anthony, Sugihara, Tomoko, Ramaswamy, Krishnan, McCracken, Rebecca, Heiselman, Darell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493265/
https://www.ncbi.nlm.nih.gov/pubmed/22747631
http://dx.doi.org/10.1186/1756-0500-5-342
_version_ 1782249229294501888
author Meadows, Eric S
Bae, Jay P
Zagar, Anthony
Sugihara, Tomoko
Ramaswamy, Krishnan
McCracken, Rebecca
Heiselman, Darell
author_facet Meadows, Eric S
Bae, Jay P
Zagar, Anthony
Sugihara, Tomoko
Ramaswamy, Krishnan
McCracken, Rebecca
Heiselman, Darell
author_sort Meadows, Eric S
collection PubMed
description BACKGROUND: While prior research has provided important information about readmission rates following percutaneous coronary intervention, reports regarding charges and length of stay for readmission beyond 30 days post-discharge for patients in a large cohort are limited. The objective of this study was to characterize the rehospitalization of patients with acute coronary syndrome receiving percutaneous coronary intervention in a U.S. health benefit plan. METHODS: This study retrospectively analyzed administrative claims data from a large US managed care plan at index hospitalization, 30-days, and 31-days to 15-months rehospitalization. A valid Diagnosis Related Group code (version 24) associated with a PCI claim (codes 00.66, 36.0X, 929.73, 929.75, 929.78–929.82, 929.84, 929.95/6, and G0290/1) was required to be included in the study. Patients were also required to have an ACS diagnosis on the day of admission or within 30 days prior to the index PCI. ACS diagnoses were classified by the International Statistical Classification of Disease 9 (ICD-9-CM) codes 410.xx or 411.11. Patients with a history of transient ischemic attack or stroke were excluded from the study because of the focus only on ACS-PCI patients. A clopidogrel prescription claim was required within 60 days after hospitalization. RESULTS: Of the 6,687 ACS-PCI patients included in the study, 5,174 (77.4%) were male, 5,587 (83.6%) were <65 years old, 4,821 (72.1%) had hypertension, 5,176 (77.4%) had hyperlipidemia, and 1,777 (26.6%) had diabetes. At index hospitalization drug-eluting stents were the most frequently used: 5,534 (82.8%). Of the 4,384 patients who completed the 15-month follow-up, a total of 1,367 (31.2%) patients were rehospitalized for cardiovascular (CV)-related events, of which 811 (59.3%) were revascularization procedures: 13 (1.0%) for coronary artery bypass graft and 798 (58.4%) for PCI. In general, rehospitalizations associated with revascularization procedures cost more than other CV-related rehospitalizations. Patients rehospitalized for revascularization procedures had the shortest median time from post-index PCI to rehospitalization when compared to the patients who were rehospitalized for other CV-related events. CONCLUSIONS: For ACS patients who underwent PCI, revascularization procedures represented a large portion of rehospitalizations. Revascularization procedures appear to be the most frequent, most costly, and earliest cause for rehospitalization after ACS-PCI.
format Online
Article
Text
id pubmed-3493265
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34932652012-11-09 Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis Meadows, Eric S Bae, Jay P Zagar, Anthony Sugihara, Tomoko Ramaswamy, Krishnan McCracken, Rebecca Heiselman, Darell BMC Res Notes Research Article BACKGROUND: While prior research has provided important information about readmission rates following percutaneous coronary intervention, reports regarding charges and length of stay for readmission beyond 30 days post-discharge for patients in a large cohort are limited. The objective of this study was to characterize the rehospitalization of patients with acute coronary syndrome receiving percutaneous coronary intervention in a U.S. health benefit plan. METHODS: This study retrospectively analyzed administrative claims data from a large US managed care plan at index hospitalization, 30-days, and 31-days to 15-months rehospitalization. A valid Diagnosis Related Group code (version 24) associated with a PCI claim (codes 00.66, 36.0X, 929.73, 929.75, 929.78–929.82, 929.84, 929.95/6, and G0290/1) was required to be included in the study. Patients were also required to have an ACS diagnosis on the day of admission or within 30 days prior to the index PCI. ACS diagnoses were classified by the International Statistical Classification of Disease 9 (ICD-9-CM) codes 410.xx or 411.11. Patients with a history of transient ischemic attack or stroke were excluded from the study because of the focus only on ACS-PCI patients. A clopidogrel prescription claim was required within 60 days after hospitalization. RESULTS: Of the 6,687 ACS-PCI patients included in the study, 5,174 (77.4%) were male, 5,587 (83.6%) were <65 years old, 4,821 (72.1%) had hypertension, 5,176 (77.4%) had hyperlipidemia, and 1,777 (26.6%) had diabetes. At index hospitalization drug-eluting stents were the most frequently used: 5,534 (82.8%). Of the 4,384 patients who completed the 15-month follow-up, a total of 1,367 (31.2%) patients were rehospitalized for cardiovascular (CV)-related events, of which 811 (59.3%) were revascularization procedures: 13 (1.0%) for coronary artery bypass graft and 798 (58.4%) for PCI. In general, rehospitalizations associated with revascularization procedures cost more than other CV-related rehospitalizations. Patients rehospitalized for revascularization procedures had the shortest median time from post-index PCI to rehospitalization when compared to the patients who were rehospitalized for other CV-related events. CONCLUSIONS: For ACS patients who underwent PCI, revascularization procedures represented a large portion of rehospitalizations. Revascularization procedures appear to be the most frequent, most costly, and earliest cause for rehospitalization after ACS-PCI. BioMed Central 2012-07-02 /pmc/articles/PMC3493265/ /pubmed/22747631 http://dx.doi.org/10.1186/1756-0500-5-342 Text en Copyright ©2012 Meadows et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Meadows, Eric S
Bae, Jay P
Zagar, Anthony
Sugihara, Tomoko
Ramaswamy, Krishnan
McCracken, Rebecca
Heiselman, Darell
Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title_full Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title_fullStr Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title_full_unstemmed Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title_short Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
title_sort rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493265/
https://www.ncbi.nlm.nih.gov/pubmed/22747631
http://dx.doi.org/10.1186/1756-0500-5-342
work_keys_str_mv AT meadowserics rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT baejayp rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT zagaranthony rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT sugiharatomoko rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT ramaswamykrishnan rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT mccrackenrebecca rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis
AT heiselmandarell rehospitalizationfollowingpercutaneouscoronaryinterventionforcommerciallyinsuredpatientswithacutecoronarysyndromearetrospectiveanalysis